Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Editorial

Look, no strings: publishing industry-funded research

CMAJ September 18, 2001 165 (6) 733;
  • Article
  • Responses
  • Metrics
  • PDF
Loading

World wide, pharmaceutical companies spend over US$40 billion annually on research and development. The cost of getting a new drug to market is as much as US$600 million.1 As costs have escalated, pharmaceutical companies have turned to contract research organizations; in the US, private research companies received 60% of pharmaceutical company research contracts last year. Gone are the days when clinical trials are conducted in the pure ether of academe by researchers whose investigations and careers are uninhibited (even if imperfectly) by the sponsor.

Pharmaceutical companies know that faulty or dishonest research leads down a long and costly road to drug withdrawals and lawsuits. Nevertheless, the pressure to come up with a winner — a drug that works and has an acceptable safety profile — is extreme. It should not surprise us when the inherent biases of research slide into deliberate distortion or the suppression of unwanted results.2,3

Integrity in clinical research requires that investigators have complete intellectual independence in conducting their studies. But, so far, specific and enforceable guidelines to safeguard the scientific independence of researchers (and ultimately, the interests of patients) have not been codified. In the face of this policy vacuum, a group of Canadian investigators have proposed a set of “rules” to govern industry–university research contracts in Canada (see page 783).4

In a similar vein, the International Committee of Medical Journal Editors has adopted tough new policies governing the publication of industry- and government-sponsored research (see page 786).5 Henceforth these 11 leading journals will require authors to attest that they “had full access to all of the data in [the] study and … [to] take complete responsibility for the integrity of the data and the accuracy of the data analysis.” In addition, editors will retain the right to review the study protocol as well as funding contracts for the study before accepting the paper for publication. CMAJ will not accept reports on research that was conducted under a contractual arrangement that did not meet these ethical standards.

Pharmaceutical companies have argued that information about a new drug's efficacy and safety is proprietary. We maintain that the ownership of such information is much broader: health research is a public good. People who volunteer to enrol in clinical trials do not intend the results of their participation to be distorted or suppressed. And the public has an additional interest in industry-funded research: as tax incentives and deductible expenses, about 70% of the costs are indirectly supported by the public purse.

In an ideal world, the necessary conditions for the disinterested conduct of research would be set by industrial sponsors themselves with fully articulated policies to ensure the scientific independence of the research they fund. No researcher should be expected to produce “findings” without full access to the data, freedom from interference in analysis and interpretation, and the liberty to publish all results, however disappointing to the shareholder they may be. In the meantime, investigators do well to arm themselves with rules for research partnerships, and editors to take on the role of watchdog. — CMAJ

References

  1. 1.↵
    Kettler H. Updating the cost of a new chemical entity. London: Office of Health Economics; 1999. Summary available: www.ohe.org/updating.htm#Updating the Cost of New Chemical Entity (accessed 2001 Aug 22).
  2. 2.↵
    Phillips RA, Hoey J. Constraints of interest: lessons at the Hospital for Sick Children. CMAJ 1998;159(8):955-7.
    OpenUrlFREE Full Text
  3. 3.↵
    Rennie D. Thyroid storm. JAMA 1997;277: 1238-43.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Lewis S, Baird P, Evans RG, Ghali WA, Wright CJ, Gibson E, et al. Dancing with the porcupine: rules for governing the university–industry relationship [editorial]. CMAJ 2001;165(6):783-5.
    OpenUrlFREE Full Text
  5. 5.↵
    Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Højgaard L, et al. Sponsorship, authorship and accountability [editorial]. CMAJ 2001; 165(6):786-8.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

CMAJ
Vol. 165, Issue 6
18 Sep 2001
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Look, no strings: publishing industry-funded research
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Look, no strings: publishing industry-funded research
CMAJ Sep 2001, 165 (6) 733;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Look, no strings: publishing industry-funded research
CMAJ Sep 2001, 165 (6) 733;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The invisible hand of the marketing department
  • Google Scholar

More in this TOC Section

  • Les répercussions des compressions budgétaires de l’AMC sur le Groupe JAMC
  • The impact of CMA budget cuts on CMAJ Group
  • L’intégration de la pratique sage-femme au Canada
Show more Éditorial

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire